Earnings Releases·Nov 4, 2026, 4:05 PM ET

CoreCivic — Third Quarter 2026 Earnings Summary

Total revenue surged 28.2% year-over-year to $744.1 million, while net income and adjusted net income grew 5,011% and 104.2% respectively, driven by a $1.8 billion gain on the sale of four facilities and the acquisition of Clinical Solutions Pharmacy.
Full-year 2026 guidance was adjusted to lower net income ($1.461B–$1.467B) but raised for adjusted diluted EPS ($1.74–$1.80), adjusted EBITDA ($442.5M–$445.5M), and normalized FFO per share ($2.78–$2.85).
Capital allocation strategy included a $500 million Accelerated Share Repurchase and an additional $500 million buyback authorization, alongside debt reduction that improved the net debt to Adjusted EBITDA leverage ratio to (0.1)x.
Operational momentum is supported by Residential segment occupancy rising to 84.0% and the activation of four new facilities, with a new five-year contract secured for the 1,600-bed Appleton Detention Facility.
Leadership transitioned to President and CEO Lucibeth Mayberry, while ongoing discussions with ICE regarding potential additional facility acquisitions remain in preliminary stages.